Ford Motor ‘s decision to cut production of its electric pick-up allows the automaker to refocus its strategy around its highly profitable hybrid vehicles, which in turn should boost its underperforming stock. Ford said Monday it’s cutting in half planned production of its all-electric F-150 Lightning pick-up truck next year due to moderating consumer demand. … Read more
CNBC’s Jim Cramer keyed in on the optionality of six of the companies that have become known as the “Magnificent Seven” during his Wednesday show. “The Magnificent Seven have the most optionality of any publicly traded companies in modern history,” Cramer said. “To sell any of them is to forget that they have this kind … Read more
Every weekday the CNBC Investing Club with Jim Cramer holds a Morning Meeting livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. 1. U.S. stocks climbed higher Thursday morning, with the S & P 500 up 0.4%, a day after the Dow Jones Industrial Average hit a record high . The rally … Read more
This year will certainly be known for tech reasserting its dominance on Wall Street. However, the powerful snapback rally of 2023 has broadened out over the past seven weeks or so to include companies whose fortunes are more closely tied to the U.S. economy. With the Federal Reserve’s interest rate hikes on pause and three … Read more
Wall Street analysts are warming up to Coterra Energy , a stock we bought more shares of just last week when it was firmly out of favor. In recent days, Citigroup, UBS and Wells Fargo all upgraded Coterra to buy-equivalent ratings, highlighting a host of fundamental reasons — including improving capital efficiency — to own … Read more
Starbucks is facing multiple challenges in major markets both internationally and in the U.S., making shareholders like us wonder if it’s a good idea to sell shares before the company’s next earnings report, which is expected in late January. “Starbucks is what I call a tough own right now,” Jim Cramer said Tuesday during the … Read more
The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled … Read more
Every weekday the CNBC Investing Club with Jim Cramer holds a Morning Meeting livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks climbed higher to start the week, with the S & P 500 reaching another 52-week high on Monday morning. Mega cap technology stocks were bolstering the market, … Read more
U.S. stocks have been trending higher since the Investing Club’s November Monthly Meeting as markets celebrate signs of cooling inflation and a seemingly less hawkish Federal Reserve . Watch our December Monthly Meeting at live noon ET and later on video. The S & P 500 has jumped 5.2% since the market close on the … Read more
